Antibody therapy training phagocytes to destroy tumors now tested on patients

(University of Turku) Developed by researchers at the University of Turku in Finland, an immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer. The antibody therapy prevented the growth of tumours in several mouse models. The development of the therapy has now progressed to patient testing in a phase I/II clinical trial.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news